{
    "info": {
        "nct_id": "NCT04662255",
        "official_title": "A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN MCL-321)",
        "inclusion_criteria": "* Confirmed MCL diagnosis\n* Previously treated with at least one prior line of systemic therapy for MCL\n* Measurable disease per Lugano criteria\n* Eastern Cooperative Oncology Group (ECOG) 0-2\n* Absolute neutrophil count ≥ 0.75 × 109/L without granulocyte-colony stimulating factor support within 7 days of screening\n* Hemoglobin ≥ 8 g/dL not requiring transfusion support or growth factors within 7 days of screening\n* Platelets ≥ 50 × 109/L not requiring transfusion support or growth factors within 7 days of screening.\n* AST and ALT ≤ 3.0 x upper limit of normal (ULN)\n* Total bilirubin ≤ 1.5 x ULN.\n* Creatinine clearance of ≥ 30 mL/min according to Cockcroft/Gault Formula\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Prior treatment with an approved or investigational BTK inhibitor\n* History of bleeding diathesis\n* History of stroke or intracranial hemorrhage within 6 months of randomization\n* History of allogeneic or autologous stem cell transplant (SCT) or chimeric antigen receptor modified T-cell (CAR-T) therapy within 60 days of randomization\n* Clinically significant cardiovascular disease\n* Prolonged QT interval corrected using Fridericia's formula (QTcF) > 470 ms on 2/3 consecutive ECGs, and mean QTcF>470 ms on all 3 ECGs\n* Known HIV infection or active HBV, HCV, or CMV infections. (Certain participants with controlled HBV infections may still be eligible)\n* Clinically significant active malabsorption syndrome or other condition likely to affect gastrointestinal (GI) absorption\n* Ongoing chronic treatment with strong cytochrome P450 3A4 (CYP3A4) inhibitors or inducers which cannot be stopped within 3-5 half lives of the CYP3A inhibitor therapy prior to start of study drug treatment.\n* Patients requiring therapeutic anticoagulation with warfarin or another Vitamin K antagonist.\n* Vaccination with live vaccine within 28 days prior to randomization",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Confirmed MCL diagnosis",
            "criterions": [
                {
                    "exact_snippets": "Confirmed MCL diagnosis",
                    "criterion": "mantle cell lymphoma (MCL) diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "confirmation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Previously treated with at least one prior line of systemic therapy for MCL",
            "criterions": [
                {
                    "exact_snippets": "Previously treated with at least one prior line of systemic therapy for MCL",
                    "criterion": "prior systemic therapy for MCL",
                    "requirements": [
                        {
                            "requirement_type": "number of prior lines",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "lines"
                            }
                        },
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "previously treated"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Measurable disease per Lugano criteria",
            "criterions": [
                {
                    "exact_snippets": "Measurable disease per Lugano criteria",
                    "criterion": "disease",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "assessment_criteria",
                            "expected_value": "Lugano criteria"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eastern Cooperative Oncology Group (ECOG) 0-2",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) 0-2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score range",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hemoglobin ≥ 8 g/dL not requiring transfusion support or growth factors within 7 days of screening",
            "criterions": [
                {
                    "exact_snippets": "Hemoglobin ≥ 8 g/dL",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 8,
                                "unit": "g/dL"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "not requiring transfusion support ... within 7 days of screening",
                    "criterion": "transfusion support",
                    "requirements": [
                        {
                            "requirement_type": "requirement within 7 days of screening",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "not requiring ... growth factors within 7 days of screening",
                    "criterion": "growth factors",
                    "requirements": [
                        {
                            "requirement_type": "requirement within 7 days of screening",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Platelets ≥ 50 × 109/L not requiring transfusion support or growth factors within 7 days of screening.",
            "criterions": [
                {
                    "exact_snippets": "Platelets ≥ 50 × 109/L",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "× 10^9/L"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "not requiring transfusion support ... within 7 days of screening",
                    "criterion": "transfusion support requirement",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": "within 7 days of screening"
                        }
                    ]
                },
                {
                    "exact_snippets": "not requiring ... growth factors within 7 days of screening",
                    "criterion": "growth factor requirement",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": "within 7 days of screening"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* AST and ALT ≤ 3.0 x upper limit of normal (ULN)",
            "criterions": [
                {
                    "exact_snippets": "AST ... ≤ 3.0 x upper limit of normal (ULN)",
                    "criterion": "AST level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3.0,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "ALT ≤ 3.0 x upper limit of normal (ULN)",
                    "criterion": "ALT level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3.0,
                                "unit": "x ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Total bilirubin ≤ 1.5 x ULN.",
            "criterions": [
                {
                    "exact_snippets": "Total bilirubin ≤ 1.5 x ULN.",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Creatinine clearance of ≥ 30 mL/min according to Cockcroft/Gault Formula",
            "criterions": [
                {
                    "exact_snippets": "Creatinine clearance of ≥ 30 mL/min according to Cockcroft/Gault Formula",
                    "criterion": "creatinine clearance",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 30,
                                "unit": "mL/min"
                            }
                        },
                        {
                            "requirement_type": "calculation method",
                            "expected_value": "Cockcroft/Gault Formula"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Prior treatment with an approved or investigational BTK inhibitor",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment with an approved or investigational BTK inhibitor",
                    "criterion": "prior treatment with BTK inhibitor",
                    "requirements": [
                        {
                            "requirement_type": "treatment history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "BTK inhibitor type",
                            "expected_value": [
                                "approved",
                                "investigational"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients requiring therapeutic anticoagulation with warfarin or another Vitamin K antagonist.",
            "criterions": [
                {
                    "exact_snippets": "Patients requiring therapeutic anticoagulation with warfarin or another Vitamin K antagonist",
                    "criterion": "therapeutic anticoagulation with warfarin or another Vitamin K antagonist",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of allogeneic or autologous stem cell transplant (SCT) or chimeric antigen receptor modified T-cell (CAR-T) therapy within 60 days of randomization",
            "criterions": [
                {
                    "exact_snippets": "History of allogeneic or autologous stem cell transplant (SCT) ... within 60 days of randomization",
                    "criterion": "stem cell transplant (SCT)",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 60,
                                "unit": "days from randomization"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "History of ... chimeric antigen receptor modified T-cell (CAR-T) therapy within 60 days of randomization",
                    "criterion": "chimeric antigen receptor modified T-cell (CAR-T) therapy",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 60,
                                "unit": "days from randomization"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of bleeding diathesis",
            "criterions": [
                {
                    "exact_snippets": "History of bleeding diathesis",
                    "criterion": "bleeding diathesis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Clinically significant cardiovascular disease",
            "criterions": [
                {
                    "exact_snippets": "Clinically significant cardiovascular disease",
                    "criterion": "cardiovascular disease",
                    "requirements": [
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Vaccination with live vaccine within 28 days prior to randomization",
            "criterions": [
                {
                    "exact_snippets": "Vaccination with live vaccine within 28 days prior to randomization",
                    "criterion": "live vaccine vaccination",
                    "requirements": [
                        {
                            "requirement_type": "time since vaccination",
                            "expected_value": {
                                "operator": ">=",
                                "value": 28,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Clinically significant active malabsorption syndrome or other condition likely to affect gastrointestinal (GI) absorption",
            "criterions": [
                {
                    "exact_snippets": "Clinically significant active malabsorption syndrome",
                    "criterion": "malabsorption syndrome",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "other condition likely to affect gastrointestinal (GI) absorption",
                    "criterion": "condition affecting gastrointestinal absorption",
                    "requirements": [
                        {
                            "requirement_type": "likelihood to affect GI absorption",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prolonged QT interval corrected using Fridericia's formula (QTcF) > 470 ms on 2/3 consecutive ECGs, and mean QTcF>470 ms on all 3 ECGs",
            "criterions": [
                {
                    "exact_snippets": "Prolonged QT interval corrected using Fridericia's formula (QTcF) > 470 ms on 2/3 consecutive ECGs",
                    "criterion": "QT interval corrected using Fridericia's formula (QTcF)",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 470,
                                "unit": "ms"
                            }
                        },
                        {
                            "requirement_type": "occurrence",
                            "expected_value": "on 2/3 consecutive ECGs"
                        }
                    ]
                },
                {
                    "exact_snippets": "mean QTcF>470 ms on all 3 ECGs",
                    "criterion": "mean QT interval corrected using Fridericia's formula (QTcF)",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 470,
                                "unit": "ms"
                            }
                        },
                        {
                            "requirement_type": "occurrence",
                            "expected_value": "on all 3 ECGs"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of stroke or intracranial hemorrhage within 6 months of randomization",
            "criterions": [
                {
                    "exact_snippets": "History of stroke ... within 6 months of randomization",
                    "criterion": "stroke",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "History of ... intracranial hemorrhage within 6 months of randomization",
                    "criterion": "intracranial hemorrhage",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known HIV infection or active HBV, HCV, or CMV infections. (Certain participants with controlled HBV infections may still be eligible)",
            "criterions": [
                {
                    "exact_snippets": "Known HIV infection",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "active HBV, HCV, or CMV infections",
                    "criterion": "HBV infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "active HBV, HCV, or CMV infections",
                    "criterion": "HCV infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "active HBV, HCV, or CMV infections",
                    "criterion": "CMV infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ongoing chronic treatment with strong cytochrome P450 3A4 (CYP3A4) inhibitors or inducers which cannot be stopped within 3-5 half lives of the CYP3A inhibitor therapy prior to start of study drug treatment.",
            "criterions": [
                {
                    "exact_snippets": "Ongoing chronic treatment with strong cytochrome P450 3A4 (CYP3A4) inhibitors or inducers",
                    "criterion": "chronic treatment with strong CYP3A4 inhibitors or inducers",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "* Absolute neutrophil count ≥ 0.75 × 109/L without granulocyte-colony stimulating factor support within 7 days of screening",
            "criterions": [
                {
                    "exact_snippets": "Absolute neutrophil count ≥ 0.75 × 10^9/L",
                    "criterion": "absolute neutrophil count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 0.75,
                                "unit": "10^9/L"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "without granulocyte-colony stimulating factor support within 7 days of screening",
                    "criterion": "granulocyte-colony stimulating factor support",
                    "requirements": [
                        {
                            "requirement_type": "absence_within_timeframe",
                            "expected_value": "no support within 7 days of screening"
                        }
                    ]
                }
            ]
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}